Improving prevention and early care for HIV-related cancers in East Africa
United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers
This program brings U.S. and East African teams together to prevent, find earlier, and speed access to treatment for people with HIV who face virus-related cancers like cervical cancer and Kaposi's sarcoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11112369 on NIH RePORTER |
What this research studies
The center builds a network linking eight institutions in the U.S. and East Africa to work on preventing and detecting cancers linked to viruses in people with HIV. It supports training and career development for emerging African investigators and U.S. junior researchers so local teams can lead studies. The program will run prevention and early-detection activities, improve diagnostic testing, and strengthen ways to connect people quickly to care. Research projects will be led by the newly trained local investigators and implemented at partner clinics in the region.
Who could benefit from this research
Good fit: People living with HIV in East Africa—especially women at risk for cervical cancer and anyone with signs or risk of Kaposi's sarcoma—who can access participating clinics would be ideal candidates for the program's screening and linkage activities.
Not a fit: People without HIV, those living outside the participating East African regions, or those with cancers not caused by viruses are unlikely to gain direct benefit from this center's activities.
Why it matters
Potential benefit: If successful, this work could lead to earlier cancer detection, better prevention, and faster treatment connections that reduce illness and death among people with HIV in East Africa.
How similar studies have performed: Previous programs have shown that targeted screening and better linkage to care can improve outcomes for cervical cancer and Kaposi's sarcoma, while the combined emphasis on local investigator training and a regional research network is a newer approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.